Recursion Pharmaceuticals Files 8-K
Ticker: RXRX · Form: 8-K · Filed: May 9, 2025 · CIK: 1601830
| Field | Detail |
|---|---|
| Company | Recursion Pharmaceuticals, Inc. (RXRX) |
| Form Type | 8-K |
| Filed Date | May 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Recursion Pharma filed an 8-K, but it's mostly procedural with no juicy details yet.
AI Summary
Recursion Pharmaceuticals, Inc. filed an 8-K on May 9, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This 8-K filing indicates Recursion Pharmaceuticals has made a regulatory submission, but lacks specific details on the nature of the events or financial implications.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without disclosing new material information that would immediately impact risk.
Key Players & Entities
- RECURSION PHARMACEUTICALS, INC. (company) — Registrant
- May 9, 2025 (date) — Date of Report
- 41 S Rio Grande Street (address) — Principal executive offices
- Salt Lake City, UT 84101 (address) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Recursion Pharmaceuticals, Inc. in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.
When was this 8-K report filed with the SEC?
The report was filed on May 9, 2025.
What is the principal executive office address for Recursion Pharmaceuticals, Inc.?
The address is 41 S Rio Grande Street, Salt Lake City, UT 84101.
What is the Commission File Number for Recursion Pharmaceuticals, Inc.?
The Commission File Number is 001-40323.
Does this filing contain any new financial statements or exhibits?
Yes, the filing indicates that 'Financial Statements and Exhibits' are included, but the specific content is not detailed in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 9, 2025 regarding RECURSION PHARMACEUTICALS, INC. (RXRX).